Dow Down 1.27% Nasdaq Down 1.49%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
45.76 Down 1.23(2.62%) 2:41PM EDT - Nasdaq Real Time Price
Prev Close:46.99
Open:47.09
Bid:45.94 x 200
Ask:46.00 x 100
1y Target Est:84.80
Beta:1.23
Earnings Date:Oct 27 - Nov 6 (Est.)
Day's Range:45.72 - 47.50
52wk Range:43.57 - 80.42
Volume:284,009
Avg Vol (3m):437,175
Market Cap:950.89M
P/E (ttm):126.76
EPS (ttm):0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LGND

Comparison

Symbol% ChgMkt Cap
LGNDDown 2.62%950.89M
LLYUp 0.38%69.76B
MRKDown 0.94%169.39B
RHHBYDown 0.57%249.92B

Key Statistics

Forward P/E (1 yr):18.90
P/S (ttm):17.98
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.55
Quarterly EPS Est (Sep-14) :0.32
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback